Skip to content
Artwork for Charged Alpha Stock Encyclopedia
BusinessInvesting

Charged Alpha Stock Encyclopedia

Colton Thomas

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close: what they do, how the numbers look, what Wall Street thinks, the bull case, the bear case. 🛠️ Check out our free beginner-friendly screening tools for stocks, ETFs, options, crypto, bonds, REITs & more at https://chargedalpha.com — no signup, no paywall. 📊 What you get in every episode: Company overview & competitive moat Full financial breakdown — valuation, revenue, margins, cash flow Analyst consensus & price targets Bull case vs. bear case Peer comparison, options flow & insider activity Key metrics to watch ⚠️ Not financial advice. For educational purposes only. Episodes are researched, written, and produced using AI-assisted tools. All data aggregated from publicly available sources. #stocks #investing #S&P500 #stockanalysis #chargedalpha #financialdata #earningsreport #earnings

Play
  • 322 episodes
  • Avg 14 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • November 11 · 13 min

    ANET Stock: The $11.4B Supply Bet Behind the AI Surge — Q3 2026

    Arista Networks, Inc. (ANET) Q3 2026 — The first post-release close rose 5.04%; the November 10 reference close was $185.02, 8.89% above the pre-release close. Arista revenue grew 58.5%, but non-cancellable supplier commitments climbed to $11.4 billion. We trace the quarter through its investment-gain EPS bridge, working capital and three valuation routes to test how much AI growth reaches owners. THE CALL: HOLD (3/5, MODERATE) — Current fair value ~$150.00 vs ~$185.02 at the November 10, 2026 close. KEY METRICS: - Revenue $3,657.6M, up 58.5% year over year - GAAP EPS $1.22; adjusted EPS $1.20; strategic investment gain $134.5M - GAAP operating margin 44.9%; adjusted operating margin 49.1% - Q4 revenue guide $3.9–$4.0B; adjusted EPS guide $1.26–$1.30 - Non-cancellable purchases $11.4B; inventory $3.210B - Cash and marketable securities $14.359B - 9M operating cash $3.977B; simple FCF proxy $3.793B What to watch: Stronger owner-cash conversion with proportionate supply exposure, or a price near $120 with the operating thesis intact. Full research packet: https://chargedalpha.com/research/anet-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 11 · 14 min

    FCX Stock: The Copper Windfall Meets a $4.5 Billion Bill — Q3 2026

    Freeport-McMoRan Inc. (FCX) Q3 2026 — October 27 earnings-day close $65.95 versus $65.16 previously; November 10 quote $60.30. The copper windfall meets a new $4.5B bill. Freeport reported higher profit despite lower copper sales, then approved the Bagdad expansion. Inventory conversion, partner claims and investment determine what common shareholders keep. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$58.00 vs ~$60.30 today. KEY METRICS: - Revenue $7.546B, +8.2% YoY - GAAP EPS $0.81; adjusted EPS $0.88 - Copper sales 749M lb, −23.3%; realized price $6.54/lb, +39.7% - CFO $1.981B less capex $1.159B = $822M FCF before partner distributions - Consolidated net debt $5.063B before leases; payout-policy net debt $1.826B - Bagdad expansion approved Nov 4: estimated $4.5B, mid-2030 first production target - HOLD 3/5; $58 base; $35–$85 scenarios; $57.85 weighted value What to watch: Q4 copper sales 875M lb and gold sales 300k oz; cash conversion at stated commodity prices; updated Bagdad capital plan. $43.50 conditional safety reference. Full research packet: https://chargedalpha.com/research/fcx-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 10 · 14 min

    SYK Stock: Growth Holds Up, but the Recovery Premium Must Be Earned | Q3 2026

    Stryker Corporation (SYK) Q3 2026 — Organic growth continued, but guidance fell and a goodwill charge exposed weaker acquisition cash expectations. Our call is HOLD, conviction 3/5, high uncertainty. Base present value $330; weighted current value $321 versus the November 9 close of $325.73. A separate $346.37 weighted November 2027 ex-dividend price assumes 9% equity return less $3.52 dividends. The model requires recovery in cash generation. This analysis is compiled with frontier AI research models, and all scripts are AI-generated. THE CALL: HOLD (3/5, HIGH UNCERTAINTY) — Base present value ~$330 vs ~$325.73 at the November 9, 2026 close. KEY METRICS: - Q3 sales $6.520B; reported and organic growth 7.7%. - GAAP operating margin 15.9%; adjusted operating margin 26.2%. - GAAP EPS $1.96; adjusted EPS $3.52; Peripheral Vascular impairment $293M. - Nine-month FCF $2.698B, before acquisitions; September net debt $11.659B. - 2026 organic guidance 6.5–7.0%; adjusted EPS $14.80–14.90. What to watch: Potential BUY near $281 with thesis intact; Q4 organic growth and cash conversion must support recovery. Full research packet: https://chargedalpha.com/research/syk-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 10 · 14 min

    TMUS Stock: Q3 2026 Earnings | Higher Bills, Higher Churn | T-Mobile

    T-Mobile US (TMUS) Q3 2026 — Revenue per account rose, but account churn increased and capex timing supported cash flow. Our call is BUY, conviction 3/5, medium uncertainty. Current fair value is $210. Our separate $230 twelve-month base target is for approximately November 2027, before dividends. The thesis depends on retention and cash after capital commitments. THE CALL: BUY (3/5, MODERATE) — Current fair value ~$210 vs ~$168.71 at the November 9, 2026 close. KEY METRICS: - Q3 service revenue $19.375B (+6.2%); postpaid ARPA $155.73 (+4.2% computed). - Monthly account churn 1.09% versus 0.97%; not phone churn. - GAAP diluted EPS $3.22; Core Adjusted EBITDA $9.620B (non-GAAP). - Operating cash $7.341B (-1.6%); adjusted FCF $5.071B (+5.3%) as cash PP&E fell. - 2026 adjusted FCF guidance $18.7B-$18.8B; our owner-cash base is lower. What to watch: Buy at $170 or below with the thesis intact; reassess if account churn exceeds 1.15% or normalized owner cash falls below $13B. Full research packet: https://chargedalpha.com/research/tmus-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 10 · 14 min

    GEV Stock: Q3 2026 Earnings | Big Backlog, Early Cash | GE Vernova

    GE Vernova (GEV) Q3 2026 — Power margins improved; customer advances fund substantial future delivery obligations. Our call is HOLD, conviction 3/5, with high uncertainty. Current fair value is $800. Our separate $875 base target is for late 2027, roughly twelve months; dated Street target horizons are unverified. Pending Trench benefits are excluded from our standalone valuation. THE CALL: HOLD (3/5, HIGH UNCERTAINTY) — Current fair value ~$800 vs ~$829.34 at the November 9, 2026 close. KEY METRICS: - Q3 revenue $12.642B; GAAP diluted EPS $4.81. - Q3 adjusted EBITDA $1.943B; issuer non-GAAP free cash flow $5.409B. - September 30 remaining performance obligations (backlog): $196.721B. - 122 GW gas commitments = 64 GW backlog + 58 GW slot reservations. - YTD issuer non-GAAP FCF $15.307B; net contract-liability/current deferred-income cash-flow increase $19.511B. Future delivery costs remain. What to watch: Accumulate at $640 or lower with the thesis intact; revisit if durable cash conversion exceeds the model. Full research packet: https://chargedalpha.com/research/gev-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 10 · 14 min

    ALAB Stock: Astera Labs Q3 2026 — Scorpio Breaks Out, Price Too High?

    Astera Labs, Inc. (ALAB) Q3 2026 — Scorpio became the largest product family, but lower gross margin, working capital and compensation matter for value per share. Our probability-weighted estimate is $173.00; uncertainty is very high. This analysis uses frontier AI research models and AI-generated scripts. THE CALL: SELL (3/5, VERY HIGH UNCERTAINTY) — base-case value ~$165 vs ~$216.87 at the November 9, 2026 close. KEY METRICS: - Q3 revenue $584.899M, up 153.7% YoY; above the prior $540–560M issuer guide - GAAP EPS $0.99; company non-GAAP EPS $1.32 - Q3 stock compensation $82.590M, or 14.1% of revenue - Nine-month FCF $268.114M: operating cash flow less cash capex, before acquisitions - Q4 company revenue guidance $730–750M - SELL · 3/5 · base $165 · weighted $173.00 · reference $216.87 (Nov 9 close) What to watch: Q4 revenue at least $740M with gross margin at least 72%, improving cash conversion and controlled dilution; potential BUY only with margin of safety around $124 and thesis intact. Full research packet: https://chargedalpha.com/research/alab-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 10 · 14 min

    KTOS Stock: Record Orders, But Who Funds the Growth? — Q3 2026

    Kratos Defense & Security Solutions, Inc. (KTOS) Q3 2026 — The November 6 close was $35.10, up a computed 5.1% from the November 5 pre-release close. November 9 is excluded as incomplete. Record orders do not automatically fund growth. Kratos accelerated in government solutions, but quarterly operating cash remained negative and shareholders supplied much of the cash cushion. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$34.00 vs ~$35.10 today. KEY METRICS: - Revenue $471.8M; +35.7% YoY; issuer organic growth 23.2% - Adjusted EBITDA $50.9M; GAAP operating loss $4.9M - Q3 operating cash −$5.2M; simple FCF −$35.4M; issuer FCF −$29.4M - Backlog $2.650B; funded $2.067B; company quarterly book-to-bill 2.2 - 2027 initial guidance revenue $2.1–2.2B and adjusted EBITDA $230–240M; cash forecast pending - Three author valuation routes $37.65 / $27.64 / $36.78; base $34; weighted scenario $35 What to watch: At the full-year review: FY26 adjusted EBITDA at least $176M, company-defined FCF use no worse than $120M, and a credible 2027 cash plan. Watch KGS adjusted margin at least 11%, improving unbilled collection and Unmanned book-to-bill at least 1.0. Dates are research checkpoints. Full research packet: https://chargedalpha.com/research/ktos-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 9 · 14 min

    VST Stock: EBITDA Surged 50% — Why Cash Tells a Different Story | Q3 2026

    Vistra Corp. (VST) Q3 2026 — VST rose 10.55% on November 6 and 18.63% through November 9 versus its pre-release close; latest close $133.92. Vistra delivered more than 50% growth in ongoing adjusted EBITDA. But next year’s guided cash-before-growth midpoint rises just 4.4%, and the acquisition financing bridge matters for common shareholders. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$130.00 vs ~$133.92 today. KEY METRICS: - Q3 revenue $6,347M, up 27.68% YoY - Ongoing adjusted EBITDA $2,378M, up 50.41% YoY - GAAP diluted EPS $3.23 versus $1.75 - Nine-month OCF $4,330M less all capex $2,319M = $2,011M - 2027 ongoing EBITDA midpoint $8,100M; cash before growth midpoint $4,700M - HOLD · 3/5 · base value $130 · price $133.92 (Nov 9 close) What to watch: A price at or below $97.50 with the thesis intact, or verified stronger normalized cash after growth spending and funding needs; reassess on weaker cash conversion or an unfunded capital gap. Full research packet: https://chargedalpha.com/research/vst-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 9 · 14 min

    CEG Stock: A $5 Quarter and a $3B Cash Test — Q3 2026

    Constellation Energy Corporation (CEG) Q3 2026 — Saved Nov 9 intraday quote $273.95, +9.60% versus the preceding $249.95 close; not a closing price. Constellation raised its annual earnings outlook and expanded long-term contracts. Q3 cash improved sharply, yet nine-month repurchases of $3.001B exceeded $1.518B of operating cash flow less total capex. Uprate investment and conditional financing make cash allocation the next test. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$285.00 vs ~$273.95 today. KEY METRICS: - Q3 revenue $9.550B, +45.4% YoY; Calpine changes the comparison - Q3 GAAP common net income $1.835B / diluted EPS $5.19 - Adjusted operating earnings $1.792B / EPS $5.06, +66.4% YoY - FY adjusted EPS guidance $12.50–$12.80; midpoint +5.4% - Q3 simple FCF $2.486B; nine-month simple FCF $1.518B - Nine-month repurchases $3.001B and dividends $459M - 2032 long-term agreements 91M annual MWh, ~45% of expected clean baseload fleet - Uprate program ~$4.3B cost; ~$3B incremental growth capital during 2028–2032 - DOE loan commitment up to $5B remains conditional - HOLD 3/5, $285 base, $185–$410 scenario range; $291.25 weighted value What to watch: Meet FY2026 adjusted EPS $12.50–$12.80, test full-year cash after total capex against buybacks, and keep uprate cost/schedule within the disclosed envelope. Conditional 25% safety reference: $213.75. Full research packet: https://chargedalpha.com/research/ceg-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 9 · 15 min

    NRG Stock: A Bigger Quarter, a Smaller Forward Step — Q3 2026

    NRG Energy, Inc. (NRG) Q3 2026 — Dated November 9 intraday snapshot $96.45, +9.24% versus November 6 close $88.29; not a completed session return. Adjusted EBITDA rose 67%, but next year’s adjusted EPS midpoint increases only 1.69%. The proposed $4B sale requires a complete bridge from lost earnings to debt and shares remaining. THE CALL: HOLD (3/5, MODERATE) — Analyst central fair value ~$110 vs ~$96.45 November 9, 2026 at 17:54:03 UTC, intraday. KEY METRICS: - Q3 revenue $9.466B, +23.98%; adjusted EBITDA $2.013B, +67.05%. - Adjusted EPS $4.68 uses basic shares; GAAP common income $544M. - FY2027 adjusted EPS midpoint $9.05, +1.69%; guidance excludes asset-sale effects. - Nine-month simple FCF $864M versus issuer FCF before growth $2.201B. - HOLD; $110 central value; 3/5 conviction; High uncertainty; $82.50 entry checkpoint. What to watch: Review at or below $82.50 with the $110 value and cash thesis intact; stronger after-investment cash and a reconciled post-sale model can change the value. Full research packet: https://chargedalpha.com/research/nrg-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 9 · 14 min

    INDI Stock: The Rebound Is Real. The Cash Test Is Next. — Q3 2026

    indie Semiconductor, Inc. (INDI) Q3 2026 — November 6 close $1.81, up 33.58% from $1.355. indie Semiconductor grew revenue 31%, with a stronger core trajectory. But nine-month free cash flow was negative $80.4M, and consolidated Wuxi revenue does not all belong to public shareholders. The rebound must become owner cash. THE CALL: SELL (3/5, MODERATE) — base-case value ~$1.00 vs ~$1.81 at the November 6, 2026 close. KEY METRICS: - Q3 revenue $70.241M, +30.9% YoY; core $40.7M - GAAP operating loss $38.997M; adjusted loss $7.196M - Q4 revenue guide $73–$81M; midpoint core $47M and Wuxi $30M - Nine-month OCF −$73.377M; cash capex $7.033M; FCF −$80.410M - Cash $134.249M; debt carrying value $429.998M - Wuxi 34.38% economic ownership despite full consolidation; sale pending - Base $1; range $0–$3; weighted $1.25; SELL 3/5 What to watch: Watch Q4 core revenue at least $47M, quarterly operating cash use at most $15M, the transaction cash bridge and economic shares versus the 250M model. $0.70 safety reference is conditional on the thesis. Full research packet: https://chargedalpha.com/research/indi-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 9 · 14 min

    AKAM Stock: The AI Contract Is Huge. So Is the Cash Bill. — Q3 2026

    Akamai Technologies, Inc. (AKAM) Q3 2026 — November 6 close $83.09, up 6.74% from $77.84. The AI contract is huge. So is the cash bill. Akamai reported $1.122B revenue and $172.1M of negative free cash flow while setting a much larger 2027–2028 cloud outlook. The September Anthropic agreement requires funding before shareholders collect the benefits. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$75.00 vs ~$83.09 today. KEY METRICS: - Revenue $1,121.961M, +6.4% reported YoY - GAAP EPS $0.77; adjusted EPS $1.77 - Security $621.892M; CIS $108.803M - Operating cash $433.037M; cash capex $605.155M; FCF −$172.118M - FY2026 adjusted EPS guide $6.47–$6.68 - Anthropic $11.6B agreement disclosed September; associated capex estimate $5.5B - Base $75; range $30–$120; weighted $75; HOLD 3/5 What to watch: Watch Q4 revenue at least $1.145B, security growth near 9%, the 24% adjusted margin guide, and a reconciled cloud capacity/cash schedule. $56.25 safety reference is conditional on the business thesis. Full research packet: https://chargedalpha.com/research/akam-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 8 · 14 min

    AXON Stock: A $130M Delay Meets a $1.2B Drone Bet — Q3 2026

    Axon Enterprise, Inc. (AXON) Q3 2026 — AXON closed at $313 on November 6, down 18.18% from the previous regular-session close. Axon removed about $130 million of federal deployments from its 2026 outlook while announcing up to roughly $1.2 billion of additional Skydio investment. Software is accelerating; cash conversion and the funding commitment decide how much of that growth reaches shareholders. THE CALL: HOLD (3/5, MODERATE) — base-case value ~$310.00 vs ~$313.00 today. KEY METRICS: - Revenue $908.554M, +27.85% YoY - Software & Services revenue $437.030M, +43.17% - Adjusted EBITDA $235.660M; GAAP operating income $42.080M - Q3 free cash flow −$18.901M; total SBC $156.365M - Q4 revenue guide $990M–$1.01B; adjusted EBITDA $245M–$250M - FY revenue guide $3.61B–$3.63B; adjusted EBITDA $924M–$929M - FY FCF guide $350M–$400M, prior $450M; implied Q4 FCF $424.515M–$474.515M - FY SBC $570M–$600M, prior $590M–$620M; prior above $620M bear flag not triggered - FY capex $130M–$150M, prior $160M–$190M; excludes new headquarters - Skydio incremental investment up to approximately $1.2B, conditional cash/stock funding What to watch: Meet the reduced FY FCF guide of $350M–$400M, meet the $990M–$1.01B Q4 revenue guide, and reconcile Skydio cash and shares. Our conditional 25% margin-of-safety reference is $232.50. Full research packet: https://chargedalpha.com/research/axon-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 8 · 14 min

    EOSE Stock: Record Sales, But Who Funds the Growth? — Q3 2026

    Eos Energy Enterprises (EOSE) Q3 2026 — Shares fell 12.1% on release day and 18.7% from the pre-release close through November 6, computed from daily closing prices. Record battery sales came with concentrated related-party revenue and a large operating loss. We examine the cash needs, factory move and financing claims behind the growth. THE CALL: SELL (3/5, MODERATE) — base-case value ~$0.60 vs ~$1.74 today. KEY METRICS: - Revenue $82.731M, up 171.1% year over year; related-party revenue $68.447M (82.7%) - Gross loss $44.203M; operating loss $79.321M; adjusted EBITDA loss $63.820M - Net income $125.043M includes substantial noncash warrant and derivative gains - Unrestricted cash $271.162M; nine-month operating cash outflow $261.591M - Debt principal $1,040.137M versus carrying value $655.757M What to watch: Gross margin above -25%, related-party revenue below 60% with sales growth, quarterly operating cash burn below $60M, and a credible financing bridge. Full research packet: https://chargedalpha.com/research/eose-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 4 · 15 min

    TLN Stock: The Buyback Uses Future Cash — Talen Q3 2026 Earnings

    Talen Energy Corporation (TLN) Q3 2026 — Fixed November 3 closing price: $357.28. Daily price history is context, not a valuation conclusion. Talen’s expanded fleet is earning more, while its accelerated buyback commits future capacity receipts. Hudson and Lana follow the actual cash, distinguish acquisition growth from organic performance, and explain why the unresolved guidance treatment makes our valuation conditional. THE CALL: HOLD (2/5, LOW; VERY HIGH UNCERTAINTY) — base-case value ~$340 vs ~$357.28 today. KEY METRICS: - Q3 revenue $1.327B; adjusted EBITDA $669M; net income attributable to shareholders $138M. - Q3 company adjusted FCF $433M versus $261M operating cash after property investment and nuclear fuel. - 2026 guidance midpoints unchanged; new 2027 midpoint adjusted EBITDA $2.675B and adjusted FCF $1.625B. - Capacity transaction: $1.343B net advance against $1.500B future receipts; scheduled diversions $432M / $757M / $311M in 2027 / 2028 / 2029. - Provisional HOLD, 2/5 conviction, Very High uncertainty. Conditional enterprise anchor $340; weighted scenario value $328; ordinary scenario range $210–475. - Cash routes are conditional: roughly $335–446 per share depending on unresolved guidance treatment. These are analyst sensitivities, not company targets. What to watch: Clarify capacity repayments and finance charges within 2027 adjusted-FCF guidance; verify actual cash after all plant investment and the final ASR share count. A potential BUY near $255 also requires the cash thesis to remain intact. Full research packet: https://chargedalpha.com/research/tln-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 4 · 14 min

    ETN Stock: Capacity Is Delivering — Can Cash Keep Up? Q3 2026

    Eaton Corporation plc (ETN) Q3 2026 — Eaton closed at $391.70 on November 3, 2026, up 7.00% from the prior close in the saved FMP snapshot. Eaton exceeded its prior margin test: organic growth reached 19% and segment margin 25.3%. Capacity is converting into operating delivery. The next question is whether cash after investment and acquisition funding earns the price. THE CALL: HOLD (3/5, MODERATE; HIGH UNCERTAINTY) — base-case value ~$390 vs ~$391.7 today. KEY METRICS: - Sales $8.947B; +28% reported, +19% organic, +8pp acquisitions, +1pp FX. - Adjusted EPS $3.68 versus GAAP diluted EPS $2.77; segment margin 25.3%. - Electrical Americas organic growth 22%; margin 29.8%, +230bp sequentially. Global reported growth 58% comprises 27% organic and 31pp Boyd. - Issuer quarterly FCF $1.034B; rounded component residual $1M. Nine-month computed FCF $2.222B. Net financial debt $19.288B, excluding operating leases. - HOLD 3/5; base $390 versus $391.70. Prior published call TRIM/$340. Bear/base/bull $250/$390/$510; 25/50/25 weighted value $385. - DCF $409.37; EPS cross-check $406.89; EBIT cross-check $399.75. Three-route mean less 4% integration reserve rounds to $390. Analyst assumptions; current perimeter, no separate Mobility windfall. - Mobility remains in current results pending its Dana combination, expected in the first four months of 2027. Final taxes, cash, debt, share exchange and departing earnings must be reconciled. What to watch: Q4 segment margin at least 25.4%, organic growth at least 13%, and Americas rolling organic orders above 20% support execution. Analyst cash/debt signposts: FY FCF at least $4.0B and net financial debt below $18.5B; downside FCF below $3.5B or debt above $20.5B. Prospective 15% safety-margin price $331.50 assumes unchanged fundamentals. Reconcile Mobility economics before a post-deal valuation. Full research packet: https://chargedalpha.com/research/etn-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 3 · 14 min

    AEHR Stock: Record Sales, Negative Cash Flow — Can the AI Ramp Pay? | Q1 FY2027 Earnings

    Aehr Test Systems (AEHR) Q1 FY2027 — $51.47 is the November 2 completed regular-session close; no earnings-related price reaction is inferred. Aehr reported record revenue and strong profit, yet operating cash was negative. The AI ramp now has to prove it can turn orders into collections. THE CALL: SELL (3/5, MODERATE) — Analyst fair-value anchor ~$25 vs ~$51.47 November 2 2026 completed regular-session close. KEY METRICS: - Q1 ended September 25; separate June transition is excluded. - Revenue $33.007M; GAAP net income $7.181M; adjusted net income $9.357M. - Operating cash −$3.054M; unrestricted cash $104.902M. - Backlog $100.9M September 25; effective backlog $109.3M November 1. - FY27 target $150M; adjusted net margin ≥20%; prior upper revenue bound unchanged. - SELL 3/5; Very High uncertainty; $25 value/$51.47 Nov 2 completed close. What to watch: Watch at or below $17.50 only with intact order quality, improving cash conversion and confirmed customer production progress. Full research packet: https://chargedalpha.com/research/aehr-q1-fy2027 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 3 · 14 min

    BWXT Stock: Cash Improved—What Does the New Portfolio Earn? — Q3 2026

    BWX Technologies (BWXT) Q3 2026 — Valuation uses the completed November 2, 2026 regular-session close of $130.47. Exact primary-source release time and timezone remain unverified; no isolated earnings-response claim is made. BWXT generated $150.5 million of quarterly free cash flow, but the portfolio is changing. Government profitability improved while Commercial margins slipped, PCG entered the results and the medical sale remained conditional. We test how much growth becomes cash for owners. THE CALL: HOLD (3/5, HIGH uncertainty) — base-case value ~$133.00 vs ~$130.47 at the November 2, 2026 completed regular-session close. KEY METRICS: - Q3 revenue $952.972M, +10.0% computed; GAAP operating income $132.077M includes $25.983M equity investee income. - GAAP diluted EPS $1.11; adjusted EPS $1.26. Consolidated net $101.980M; attributable net $101.712M. - Government operating margin 19.2%; Commercial 8.4%, both computed from issuer segment data. - Q3 CFO $202.715M − capex $52.263M = FCF $150.452M, reported $150.5M; +58.55% computed. - PCG cash purchase $216.8M closed July 1; medical transaction up to $800M remains conditional, with minority interest retained. - FY2026 revenue ~$3.8B; adjusted EBITDA ~$667M; adjusted EPS $4.72–4.77; FCF $350–360M. - Valuation routes $111.47 equity cash, $142.35 adjusted earnings, $144.29 enterprise multiple; analyst assumptions. - HOLD · 3/5 · $133 fair value · $95–175 scenarios · $134 weighted scenario value. What to watch: Below $115 with the thesis intact, or sustained cash conversion and a clearer continuing-business perimeter that support higher fair value. Monitor FY2026 FCF $350–360M, Government and Commercial margins, contract capital and medical closing economics. Full research packet: https://chargedalpha.com/research/bwxt-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 3 · 14 min

    GLW Stock: Customers Fund the Factories—Who Keeps the Cash? — Q3 2026

    Corning (GLW) Q3 2026 — Valuation uses the completed November 2, 2026 regular-session close of $123.20; the release clock is unconfirmed. Optical sales grew 44%, and customers are helping fund Corning’s expansion. But deposits are consumed as products ship, while core earnings and adjusted cash flow need separate hedge reconciliations. We test when the buildout becomes recurring cash for shareholders. THE CALL: HOLD (3/5, HIGH uncertainty) — base-case value ~$110.00 vs ~$123.20 at the completed November 2, 2026 regular-session close. KEY METRICS: - Q3 2026 GAAP revenue $4,855M versus $4,100M; core revenue $5,081M versus $4,272M. - Optical sales $2,379M, up 44.0% computed; segment net income $532M versus $295M. - GAAP diluted EPS $0.78; core diluted EPS $0.91. Core currency methodology changed April 1, 2026. - Q3 OCF $1,061M less capex $545M = computed $516M; issuer adjusted FCF $661M adds $145M hedge receipts. - Q3 hedge premiums $43M; adjusted FCF less premiums = analytical $618M. - 9M customer deposits/government incentives +$639M; Q3 alone −$70M. Accelerated receivables $442M at September 30. - Q4 core guidance: sales $5.2–5.3B and EPS $0.96–1.00. - HOLD · 3/5 · $110 fair value · $95–125 range · $116.25 weighted scenario value. What to watch: A price below $95 with the thesis intact, or stronger recurring cash that lifts fair value above price; monitor Q4 core guidance, optical margin, Solar profitability, receivable acceleration and diluted shares. Full research packet: https://chargedalpha.com/research/glw-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • November 2 · 14 min

    TSEM Stock: Customers Fund Capacity. What Is the 2028 Promise Worth? | Q3 2026

    Tower Semiconductor (TSEM) Q3 2026 — Reference price $155.32 at the November 2, 2026 completed-session close; −6.7% versus the prior close, computed from dated daily prices. Tower’s customers are funding capacity before delivery. The $3.6B 2028 revenue model requires qualification, spending and profitable shipments. Customer advances validate demand but also create obligations; our question is how much of the expansion becomes common-owner cash. THE CALL: HOLD (3/5, HIGH UNCERTAINTY) — base-case value ~$150.00 vs ~$155.32 at the November 2, 2026 completed-session close. KEY METRICS: - Q3 revenue $526.161M, +33.0% YoY; gross profit $178.759M; operating profit $127.135M - GAAP parent net income $120.256M; diluted EPS $1.05 versus adjusted diluted EPS $1.15 - RF infrastructure is 56% of revenue versus 27%; broader than SiPho and not a separate profit segment - Q4 revenue guide $600M ±5%, or $570–630M; FY midpoint computed at ~$2.000B - 2028 target business model $3.6B revenue / $1.2B net profit; not guaranteed parent-attributable earnings - Japan dual-track net investment plan ~$3B after ~$1B grants; track two expected accretive from 2029 - 9M OCF $872.093M less net equipment investment $533.636M gives FCF $338.457M; net advances $305.430M; ex-advance diagnostic $33.027M - Q3 OCF $185.159M less net equipment investment $190.683M gives −$5.524M FCF; removing $22.848M advances gives −$28.372M - HOLD; $150 base, $90–220 range, $152.50 weighted value; conditional entry $120; High uncertainty - Prior Q2 metadata: AVOID, fair value $160 at $239.53 reference; current operational triggers graded separately What to watch: Fresh-buy checkpoint $120 with intact economics. Watch Q4 revenue at least $600M, gross margin above 35%, positive cash after net equipment spending and advances in two successive quarters, and track-one qualification by the initial Q4 2027 schedule. Material advance repayments, penalties or delays would require revaluation. Full research packet: https://chargedalpha.com/research/tsem-q3-2026 Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Showing 21–40 of 322 episodes